苯二氮䓬类药物戒斷症候群

苯二氮䓬类药物戒斷症候群又称苯二氮卓戒断综合征英語:),通常缩写为苯并戒断()或BZD戒断() ,是指服用苯二氮䓬类药物(可能因医疗原因或娱乐性原因用药)并产生生理依赖性后,减少用量或停药时产生的藥物戒斷症状。觅药行为或按处方服药均可能导致生理依赖性与药物成瘾(或二者之一)以及因此产生的戒断症状。某些症状可能持续数年。苯二氮䓬类药物戒斷症候群的显著特征症状包括:睡眠障碍、易怒、紧张焦虑恐慌發作、手颤、发抖、出汗、难以集中精神、意识混乱和认知障碍、记忆减退、恶心干呕、体重下降、心悸、头痛、肌肉疼痛僵硬、知觉变化、幻觉癲癇發作思覺失調[1]以及自杀[2][3]。此外,这些症状可能时好时坏,每日或每周的严重程度不一,而不是持续稳定好转。[4]

苯二氮䓬类药物戒斷症候群
类型戒断状态[*]苯二氮䓬类药物依赖性
分类和外部资源
醫學專科精神病学
ICD-10F13.3 (持续用药后)

苯二氮䓬类戒断症状可能很严重,症状复杂且常常长期持续。[5][6]长期使用苯二氮䓬类(即每日用药,持续至少三个月)[7]可能有更高的药物依赖风险[8],亦可能造成用量增加、药效降低、增加事故和摔倒的概率(尤其是老年人),[9]还可能与认知、[10]神经系统和智力损伤有关[11]。因此不宜长期使用苯二氮䓬类药物。[8]将苯二氮䓬类药物作为短效安眠药使用,在入睡时可能有效,但可能因戒断反应而导致后半段睡眠质量不佳。[12]尽管如此,对于长期服用苯二氮䓬类药物者,不应违背其意愿强迫停药。[5]

苯二氮䓬类戒断可能有重症反应,甚至产生癫痫发作等危及生命的症状,[13]尤其是突然戒断或减量过快的大剂量或长期用药者。[5]然而逐步减量或相对用量较少的短期用药者亦可能出现重症戒断反应,[14]在动物模型中甚至曾有单次大剂量用药后戒断出现重症反应。[15][16]少数人会出现遷延性戒斷症狀,症状可能在戒断后数月甚至数年内持续,维持在亚急性状态。缓慢而逐步的减少药物用量能使遷延性戒斷症狀的出现概率尽可能降低。[17]

长期使用苯二氮䓬类药物会导致神经适应,降低药物效果,造成耐受依赖[18]即使是持续服用治疗剂量期间,长期使用苯二氮䓬类药物亦可能引起类似戒断反应的症状,尤其是在服药间隔期。[19]停药或减少用量后,用药者即会出现药物戒断症状,直至其生理适应恢复。[20]这些反跳症状可能与最初服药前的病症相同,亦可能是戒斷症候群的一部分。[21]在重症病例中,戒断反应可能会恶化,或与严重的精神疾病相似,如狂躁精神分裂症,尤其在大剂量用药者中还会出现癲癇重積狀態[22]若不能正确诊断出戒斷症候群,可能会误诊为服药前的疾病复发而需要继续用药,导致戒断失败、重新开始用药,而重新用药往往比之前的剂量更大。[22]

提高戒断成功率的方法包括:提升对戒断反应的意识,针对用药者的戒断反应严重程度而制定个人化的逐步戒断方法,以及增加其他替代方法辅助,如使用药者安心、参加苯二氮䓬类药物戒断互助小组。这些方法都能有效提高戒断的成功率。[23][24]

症状和体征

地西泮,其2毫克与5毫克片剂常用于治疗苯二氮䓬类戒断反应[25]
氯二氮平,其5毫克胶囊剂有时可作为地西泮的替代药物,用于治疗苯二氮䓬类戒断反应。氯二氮平与地西泮都有较长的消除半衰期和长效活性代謝產物

苯二氮䓬类、巴比妥类等镇静安眠药物或酒精成瘾者在停用后会产生严重的戒断反应症状。《临床成人精神医学手册》显示这些戒断症状比鸦片类药物的戒断症状更严重、危害更大。[26]使用者在停药时一般甚少获得相关建议和支持。[27]一些戒断症状与用药治疗之前的病症相同,[21]可能症状严重或长期持续。半衰期较长的苯二氮䓬类药物可能在停用长达三周之后才会出现戒断反应,而半衰期较短的药物则较早出现戒断反应,一般在停用24-48小时后即会出现。[28]不同剂量用药者的戒断症状种类可能没有重大差异,但大剂量用药者的症状严重程度往往更高。[29]

在用药量减少时,服药者可能会首次出现戒断反应,包括失眠、焦虑、痛苦、体重下降、晕眩、夜汗、肌肉抽搐、恐慌发作、抑郁、失实症、偏执等。这些症状更常见于短效苯二氮䓬类停药时,例如三唑仑等药物。[22][30]日间症状可能在夜间用药给药数日至数周后出现,[31][32]亦可能出现于佐匹克隆Z药物使用者。[33]即使是间歇服用苯二氮䓬类,[34]亦可能在戒断后出现失眠症状反弹,可能比服药前更加严重。[35][36]

逐步或突然减少药量可能出现下列症状:

迅速停药可能会引发更严重的症状:

参考来源

  1. Petursson, H. . Addiction. 1994, 89 (11): 1455–9. PMID 7841856. doi:10.1111/j.1360-0443.1994.tb03743.x.
  2. Colvin, Rod. 3. United States of America: Addicus Books. 26 August 2008: 74–76. ISBN 978-1-886039-88-9.
  3. Dodds TJ. . Primary Care Companion for CNS Disorders. 2017, 19 (2). PMID 28257172. doi:10.4088/PCC.16r02037.
  4. C. Heather Ashton DM. . Institute of Neuroscience, Newcastle University. [29 April 2013]. (原始内容存档于2019-04-04). Benzodiazepines : How they work and how to withdraw
  5. Professor Heather Ashton. . 2002 [2018-04-02]. (原始内容存档于2012-10-18).
  6. O'Connor, RD. . NIDA research monograph. 1993, 131: 266–9. PMID 8105385.
  7. Voshaar, R. C. O.; Couvée, JE; Van Balkom, AJ; Mulder, PG; Zitman, FG. . British Journal of Psychiatry. 2006, 189 (3): 213–20. PMID 16946355. doi:10.1192/bjp.189.3.213.
  8. Nutt, David. . Trends in Pharmacological Sciences. 1986, 7: 457–60. doi:10.1016/0165-6147(86)90420-7.
  9. De Gier, N.; Gorgels, W.; Lucassen, P.; Oude Voshaar, R.; Mulder, J.; Zitman, F. . Family Practice. 2010, 28 (3): 253–9. PMID 21193495. doi:10.1093/fampra/cmq113.
  10. Authier, Nicolas; Boucher, Alexandra; Lamaison, Dominique; Llorca, Pierre-Michel; Descotes, Jacques; Eschalier, Alain. . Thérapie. 2009, 64 (6): 365–70. PMID 20025839. doi:10.2515/therapie/2009051.
  11. Heberlein, A.; Bleich, S.; Kornhuber, J.; Hillemacher, T. [Benzodiazepine Dependence: Causalities and Treatment Options]. Fortschritte der Neurologie · Psychiatrie. 2008, 77 (1): 7–15. PMID 19101875. doi:10.1055/s-0028-1100831 (德语).
  12. Lee-chiong, Teofilo. . Oxford University Press, USA. 24 April 2008: 468. ISBN 0-19-530659-7.
  13. Evans, Katie; Sullivan, Michael J. . 2nd. Guilford Press. 2001: 52–3 [2018-04-02]. ISBN 978-1-57230-446-8. (原始内容存档于2018-05-03).
  14. Lader, M. . The Journal of Clinical Psychiatry. 1987,. 48 Suppl: 12–6. PMID 2891684.
  15. Boisse, NR; Periana, RM; Guarino, JJ; Kruger, HS; Samoriski, GM. . Journal of Pharmacology and Experimental Therapeutics. 1986, 239 (3): 775–83. PMID 3098961.
  16. Boisse, NR; Periana, RM; Guarino, JJ; Kruger, HS. . NIDA research monograph. 1986, 67: 197–201. PMID 3092067.
  17. Professor Heather Ashton. . Comprehensive Handbook of Drug & Alcohol Addiction. 2004 [2018-04-02]. (原始内容存档于2020-09-28).
  18. Allison, C; Pratt, J.A. . Pharmacology & Therapeutics. 2003, 98 (2): 171–95. PMID 12725868. doi:10.1016/S0163-7258(03)00029-9.
  19. Herman, JB; Brotman, AW; Rosenbaum, JF. . The Journal of Clinical Psychiatry. 1987,. 48 Suppl: 22–8. PMID 2889722.
  20. Allgulander, C; Bandelow, B; Hollander, E; Montgomery, SA; Nutt, DJ; Okasha, A; Pollack, MH; Stein, DJ; Swinson, RP; World Council Of, Anxiety. . CNS Spectrums. 2003, 8 (8 Suppl 1): 53–61. PMID 14767398.
  21. Salzman, Carl. . Journal of Psychiatric Research. 1993, 27: 97–110. PMID 7908335. doi:10.1016/0022-3956(93)90021-S.
  22. Gabbard, Glen O. . American Psychiatric Publishing. 15 May 2007: 209–211. ISBN 1-58562-216-8.
  23. Onyett, SR. . The Journal of the Royal College of General Practitioners. 1989, 39 (321): 160–3. PMC 1711840可免费查阅. PMID 2576073.
  24. Ashton, Heather. . Journal of Substance Abuse Treatment. 1991, 8 (1–2): 19–28. PMID 1675688. doi:10.1016/0740-5472(91)90023-4.
  25. Soyka M. . The New England Journal of Medicine. 2017, 376 (12): 1147–1157. PMID 28328330. doi:10.1056/NEJMra1611832.
  26. Lindsay, S. J. E. . Psychology Press. 1994: 363 [2018-04-05]. ISBN 9780415072168. (原始内容存档于2019-09-05).
  27. Authier, N.; Balayssac, D.; Sautereau, M.; Zangarelli, A.; Courty, P.; Somogyi, A.A.; Vennat, B.; Llorca, P.-M.; Eschalier, A. . Annales pharmaceutiques françaises. 2009, 67 (6): 408–13. PMID 19900604. doi:10.1016/j.pharma.2009.07.001.
  28. Committee on Safety of Medicines. . British National Formulary. 2007 [17 September 2007].需註冊
  29. Murphy, S. M.; Tyrer, P. . British Journal of Psychiatry. 1991, 158 (4): 511–6. PMID 1675901. doi:10.1192/bjp.158.4.511.
  30. Adam, Kirstine; Oswald, I. . Pharmacopsychiatry. 2008, 22 (3): 115–9. PMID 2748714. doi:10.1055/s-2007-1014592.
  31. Scharf, Martin B; Kales, Judith A; Bixler, EO; Jacoby, JA; Schweitzer, PK. . Clinical Pharmacology & Therapeutics. 1982, 31 (2): 175–9. PMID 6120058. doi:10.1038/clpt.1982.27.
  32. Walsh, James K; Schweitzer, Paula K; Parwatikar, Sadashiv. . Clinical Pharmacology & Therapeutics. 1983, 34 (4): 496–500. PMID 6617072. doi:10.1038/clpt.1983.203.
  33. Fontaine, Réjean; Beaudry, Paul; Le Morvan, Patrick LE; Beauclair, Linda; Chouinard, GUY. . International Clinical Psychopharmacology. 1990, 5 (3): 173–83. PMID 2230061. doi:10.1097/00004850-199007000-00002.
  34. Kales, Anthony; Manfredi, Rocco L; Vgontzas, Alexandras N; Bixler, Edward O; Vela-Bueno, Antonio; Fee, Eric C. . Clinical Pharmacology & Therapeutics. 1991, 49 (4): 468–76. PMID 2015735. doi:10.1038/clpt.1991.55.
  35. Kales, Anthony; Bixler, Edward O.; Soldatos, Constantin R.; Jacoby, Judith A.; Kales, Joyce D. . Pharmacology. 1986, 32 (3): 121–30. PMID 3960963. doi:10.1159/000138160.
  36. Bonnet, M H; Arand, D L. . International Clinical Psychopharmacology. 1999, 14 (2): 81–9. PMID 10220122. doi:10.1097/00004850-199903000-00004.
  37. Saxon, L.; Hjemdahl, P.; Hiltunen, A. J.; Borg, S. . Psychopharmacology. 1997, 131 (2): 153–60. PMID 9201803. doi:10.1007/s002130050278.
  38. Terao, T; Yoshimura, R; Terao, M; Abe, K. . Biological Psychiatry. 1992, 31 (2): 212–3. PMID 1737083. doi:10.1016/0006-3223(92)90209-I.
  39. Lader, Malcolm. . Journal of Psychosomatic Research. 1994, 38: 113–23; discussion 118–23. PMID 7799243. doi:10.1016/0022-3999(94)90142-2.
  40. Mintzer, M. Z.; Stoller, K. B.; Griffiths, R. R. . Psychopharmacology. 1999, 147 (2): 200–9. PMID 10591888. doi:10.1007/s002130051161.
  41. Mendelson, WB; Weingartner, H; Greenblatt, DJ; Garnett, D; Gillin, JC. . Sleep. 1982, 5 (4): 350–60. PMID 6761826.
  42. Schöpf, J. . Pharmacopsychiatry. 2008, 16 (1): 1–8. PMID 6131447. doi:10.1055/s-2007-1017439.
  43. Mintzer, Miriam Z.; Griffiths, Roland R. . Psychopharmacology. 2004, 178 (2–3): 259–67. PMID 15452683. doi:10.1007/s00213-004-2009-1.
  44. Biswas, AK; Feldman, BL; Davis, DH; Zintz, EA. . Clinical Toxicology. 2005, 43 (3): 207–9. PMID 15902797. doi:10.1081/clt-200053099.
  45. Bismuth, C; Le Bellec, M; Dally, S; Lagier, G. . La Nouvelle presse medicale. 1980, 9 (28): 1941–5. PMID 6106922.
  46. Loeb, P; Adnet, P; Boittiaux, P; Forget, AP; Mille, FX. [Benzodiazepine withdrawal masquerading as surgical abdominal syndrome]. Annales Françaises d'Anesthésie et de Réanimation. 1997, 16 (5): 521–2. doi:10.1016/S0750-7658(97)83345-X (法语).
  47. . Benzo.org.uk. [2018-04-05]. (原始内容存档于2019-04-04).
  48. Pelissolo, A; Bisserbe, JC. . L'Encéphale. 1994, 20 (2): 147–57. PMID 7914165.
  49. Pecknold, J.C. . Journal of Psychiatric Research. 1993, 27: 155–170. doi:10.1016/0022-3956(93)90025-W.
  50. Kliniska Färdigheter: Informationsutbytet Mellan Patient Och Läkare, LINDGREN, STEFAN, ISBN 91-44-37271-X (Swedish)
  51. Drummond, Lynne M.; Matthews, Helen P. . Journal of Nervous and Mental Disease. 1988, 176 (11): 688–91. PMID 3183654. doi:10.1097/00005053-198811000-00008.
  52. Matthews, HP; Drummond, LM. . British Journal of Psychiatry. 1987, 150: 272. PMID 3651695. doi:10.1192/s0007125000122810.
  53. Shader, RI; Greenblatt, DJ. . British Journal of Clinical Pharmacology. 1981,. 11 Suppl 1 (Suppl 1): 5S–9S. PMC 1401641可免费查阅. PMID 6133535. doi:10.1111/j.1365-2125.1981.tb01832.x.
  54. Pagel, J. F.; Parnes, Bennett L. . Primary Care Companion to the Journal of Clinical Psychiatry. 2001, 3 (3): 118–125. PMC 181172可免费查阅. PMID 15014609. doi:10.4088/PCC.v03n0303.
  55. Van Engelen, BG; Gimbrere, JS; Booy, LH. . Annals of Pharmacotherapy. 1993, 27 (5): 579–81. PMID 8347907. doi:10.1177/106002809302700509.
  56. Beeley, L. . BMJ. 1991, 302 (6790): 1465. doi:10.1136/bmj.302.6790.1465.
  57. Mellor, CS; Jain, VK. . Canadian Medical Association Journal. 1982, 127 (11): 1093–6. PMC 1862031可免费查阅. PMID 7139456.
  58. Olajide, Dele; Lader, Malcolm. . Psychological Medicine. 2009, 14 (4): 937–40. PMID 6152745. doi:10.1017/S0033291700019899.
  59. Rosebush, Patricia I.; Mazurek, Michael F. . Journal of Clinical Psychopharmacology. 1996, 16 (4): 315–9. PMID 8835707. doi:10.1097/00004714-199608000-00007.
  60. Deuschle, M.F.; Lederbogen, F. . Pharmacopsychiatry. 2001, 34 (1): 41–2. PMID 11229621. doi:10.1055/s-2001-15188.
  61. Kanemoto, Kousuke; Miyamoto, Toshio; Abe, Ryuji. . Seizure. 1999, 8 (6): 364–6. PMID 10512781. doi:10.1053/seiz.1999.0309.
  62. Metten, Pamela; Crabbe, John C. . Pharmacology Biochemistry and Behavior. 1999, 63 (3): 473–9. PMID 10418790. doi:10.1016/S0091-3057(99)00017-9.
  63. Haque, W; Watson, DJ; Bryant, SG. . Texas Medicine. Vol. 86 no. 1. 1990: 44–7. PMID 2300914.
  64. De Bard, ML. . American Journal of Psychiatry. 1979, 136 (1): 104–5. PMID 103443. doi:10.1176/ajp.136.1.104.
  65. Provini, F.; Cortelli, P.; Montagna, P.; Gambetti, P.; Lugaresi, E. . Revue Neurologique. 2008, 164 (8–9): 692–700. PMID 18805303. doi:10.1016/j.neurol.2007.11.003.
  66. Berezak, A.; Weber, M.; Hansmann, J.; Tulasne, P.A.; Laporte, B.; Ould Ouali, A. [Benzodiazepine physical dependence in traumatology]. Annales Françaises d'Anesthésie et de Réanimation. 1984, 3 (5): 383–4. doi:10.1016/S0750-7658(84)80078-7 (法语).
  67. Turkington, Douglas; Gill, Paul. . Journal of Affective Disorders. 1989, 17 (1): 93–5. PMID 2525581. doi:10.1016/0165-0327(89)90028-1.
  68. Lapierre, YD; Labelle, A. . The Canadian Journal of Psychiatry. 1987, 32 (8): 697–8. PMID 3690487. doi:10.1177/070674378703200812.
  69. Kawajiri, M; Ohyagi, Y; Furuya, H; Araki, T; Inoue, N; Esaki, S; Yamada, T; Kira, J. . Rinsho Shinkeigaku. 2002, 42 (2): 136–9. PMID 12424963.
  70. Strawn, Jeffrey; Keck Jr, PE; Caroff, SN. . American Journal of Psychiatry. 2007, 164 (6): 870–6. PMID 17541044. doi:10.1176/ajp.2007.164.6.870.
  71. Khan, A; Joyce, P; Jones, AV. . The New Zealand medical journal. 1980, 92 (665): 94–6 [2018-04-05]. PMID 6107888. (原始内容存档于2019-12-02).
  72. Peh, LH; Mahendran, R. . Singapore medical journal. 1989, 30 (1): 72–3. PMID 2595393.
  73. Fruensgaard, K. . Acta Psychiatrica Scandinavica. 1976, 53 (2): 105–18. PMID 3091. doi:10.1111/j.1600-0447.1976.tb00065.x.
  74. Einarson, A; Selby, P; Koren, G. . Journal of Psychiatry & Neuroscience. 2001, 26 (1): 44–8. PMC 1408034可免费查阅. PMID 11212593.
  75. Citrome, Leslie; Volavka, Jan. . Psychiatric Clinics of North America. 1999, 22 (4): 789–801. PMID 10623971. doi:10.1016/S0193-953X(05)70126-X.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.